Hello all,
My question: Is radiation treatment the way to go? I am newly diagnosed with Biochemical Recurrent PC.
From Dr. Childs notes:Date of diagnosis: 4.28.15 Stage: T2c, N0, MX Gleason grade: 7 (3+4) after RP
Date of last biopsy: 4.28.15 PSA density: PSA: doubling 4.3 months
Genetic testing performed and result: OncotypeDX 35, 30% chance of unfavorable pathology
Primary Cancer treatment: S/p RALRP (Kuhn) (09.18.15)
Most recent cancer staging imaging date and results: MRIp and WBB 2.2020 negative for disease
PSA trend: 0.212 (6.18.20), 0.2 (4.30.20), 0.12 (2.19.20) 0.164 (1.27.20), 0.111 (11.13.19), 0.1 (10.30.19), 0.06 (12.19.18), 0.05 (6.20.18), 0.03 (12.18.17), 0.02 (5.30.17), 0.01 (11.30.16), 0.01 (8.30.16), 0.01 (4.20.16), 0.00 (1.20.16), 0.02 (10.19.15).
*Axumin scan has been denied a few times due to PSA < 1.0
Assessment:
1. Prostate Cancer: Pros Bx (MAC) (04.28.15): 5 cores Gleason 7(4+3); S/p RALRP (Kuhn) (09.18.15), Path: Gleason 7(3+4); Stage: T2c, N0, MX; The right soft tissue/capsular margin is focally involved by tumor. Last PSA: 0.12 (2.19.20) down from 0.164 (1.27.20) Patient has recovered urinary and sexual function.
* Since prior visit, pt has seen Dr. Wang for evaluation of radiation tx. Dr. Wang recommended pt begin IGRT with adujuvant ADT x 6 months
2. Hypogonadism: Not treating due to BCR. Decreasing. Last testo: 250 (6.18.20), 247 (4.30.20), 224 (10.30.19), 265 (12.19.18)
2. Microscopic hematuria: Asymptomatic. UA clear (1.30.20); Trace-intact blood per UA (12.19.18)
Data:
- UA (1.30.20) Clear
- UA: blo/negative (10.30.19)
- PSA: 0.212 (6.18.20), 0.2 (4.30.20), 0.12 (2.19.20) 0.164 (1.27.20), 0.111 (11.13.19), 0.1 (10.30.19), 0.06 (12.19.18), 0.05 (6.20.18), 0.03 (12.18.17), 0.02 (5.30.17), 0.01 (11.30.16), 0.01 (8.30.16), 0.01 (4.20.16), 0.00 (1.20.16), 0.02 (10.19.15)
- PSA: doubling 4.3 months - Prostate size: 52.2 cc
- Testosterone: 250 (6.18.20), 247 (4.30.20), 224 (10.30.19), 265 (12.19.18)
- Vitamin D 25-hydroxy: 27.0 (4.30.20)
- Alkaline Phosphate: 70 (6.18.20), 58 (1.27.20)
- LDH: 143 (4.30.20), 145 (1.27.20)
- CT A/P (01.25.19): negative for mets. 3.2 cm infrarenal abd aortic aneurysm
- NM Bone Scan (02.06.19): no evidence of skeletal mets
-MRI prostate fossa 2.12.20: negative
- NM Bone Scan (2.25.20): no evidence of skeletal mets
- OncotypeDX 35, 30% chance of unfavorable pathology
Plan:
- Discussed current and previous sxs.
-insurance has denied Axumin
- Discussed PSA trends today, scan negative; R1 on path and PSAV suggest local recurrence; I am in favor of salvage tx given his young age/life expectancy and his preference and desire to avoid ADT long term.
- Discussed IGRT for tx for prostate cancer - procedure details, risk, and benefits reviewed.
- Discussed 6 months of ADT for tx of prostate cancer - procedure details, risk, and benefits reviewed.
- Recommended that pt perform ADT alongside IGRT for tx for prostate cancer.
- Discussed Lupron Q-6 months vs. Firmagon Q-1 month for ADT tx. Patient had interest in Firmagon to start but has elected Lupron
- Discussed Axumin scan procedure; insurance has previously denied. - procedure details, risk, and benefits reviewed Pt is interested in cash pay, but I think there is a lower chance it will change management given his history
- 6 month Lupron today.
he would like IGRT locally and wants to go to Landmark, will refer to Foster Lasley MD
So I am going to meet RO Dr. Lasley today for a consult. I welcome any and all advice on my current situation and how best to navigate my treatment going forward.
Thank You in advance,
John